Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
J Transl Med. 2022 Aug 12;20(1):356. doi: 10.1186/s12967-022-03550-0.
Long non-coding RNAs (lncRNAs) are essential regulators of tumorigenesis and the development of colorectal cancer (CRC). Here, we aimed to investigate the role of lncRNA GAS6-AS1 in CRC and its potential mechanisms.
Bioinformatics analyses evaluated the level of GAS6-AS1 in colon cancer, its correlation with clinicopathological factors, survival curve and diagnostic value. qRT-PCR were performed to detect the GAS6-AS1 level in CRC samples and cell lines. The CCK8, EdU, scratch healing, transwell assays and animal experiments were conducted to investigate the function of GAS6-AS1 in CRC. RNA immunoprecipitation (RIP) and dual-luciferase reporter gene analyses were carried out to reveal interaction between GAS6-AS1, TRIM14, FUS, and miR-370-3p/miR-1296-5p.
GAS6-AS1 was greatly elevated in CRC and positively associated with unfavorable prognosis of CRC patients. Functionally, GAS6-AS1 positively regulates CRC proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro and induces CRC growth and metastasis in vivo. Moreover, GAS6-AS1 exerted oncogenic function by competitively binding to miR-370-3p and miR-1296-5p, thereby upregulating TRIM14. Furthermore, we verified that GAS6-AS1 and TRIM14 both interact with FUS and that GAS6-AS1 stabilized TRIM14 mRNA by recruiting FUS. Besides, rescue experiments furtherly demonstrated that GAS6-AS1 facilitate progression of CRC by regulating TRIM14.
Collectively, these findings demonstrate that GAS6-AS1 promotes TRIM14-mediated cell proliferation, migration, invasion, and EMT of CRC via ceRNA network and FUS-dependent manner, suggesting that GAS6-AS1 could be utilized as a novel biomarker and therapeutic target for CRC.
长链非编码 RNA(lncRNA)是肿瘤发生和结直肠癌(CRC)发展的重要调节因子。在这里,我们旨在研究 lncRNA GAS6-AS1 在 CRC 中的作用及其潜在机制。
生物信息学分析评估了 GAS6-AS1 在结肠癌中的水平、与临床病理因素的相关性、生存曲线和诊断价值。qRT-PCR 用于检测 CRC 样本和细胞系中的 GAS6-AS1 水平。CCK8、EdU、划痕愈合、Transwell 测定和动物实验用于研究 GAS6-AS1 在 CRC 中的功能。RNA 免疫沉淀(RIP)和双荧光素酶报告基因分析用于揭示 GAS6-AS1、TRIM14、FUS 和 miR-370-3p/miR-1296-5p 之间的相互作用。
GAS6-AS1 在 CRC 中显著上调,与 CRC 患者的不良预后呈正相关。功能上,GAS6-AS1 可正向调节 CRC 细胞的增殖、迁移、侵袭和上皮间质转化(EMT),并在体内诱导 CRC 的生长和转移。此外,GAS6-AS1 通过竞争性结合 miR-370-3p 和 miR-1296-5p 发挥致癌作用,从而上调 TRIM14。此外,我们验证了 GAS6-AS1 和 TRIM14 均与 FUS 相互作用,GAS6-AS1 通过募集 FUS 稳定 TRIM14 mRNA。此外,挽救实验进一步表明,GAS6-AS1 通过调节 TRIM14 促进 CRC 的进展。
总之,这些发现表明,GAS6-AS1 通过 ceRNA 网络和 FUS 依赖性方式促进 TRIM14 介导的 CRC 细胞增殖、迁移、侵袭和 EMT,提示 GAS6-AS1 可作为 CRC 的新型生物标志物和治疗靶点。